[AsCNP_O1] Oral Session 1
Dementia & Neurological Disorders

[AsCNP-O1-10] Kynurenine 3-monooxygenase regulates expression of depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptor by kynurenic acid

^○Akihiro MOURI¹, Yuko MORI², Kazuo KUNISAWA^{1, 3}, Mami HIRAKAWA¹, Tomoaki TESHIGAWARA², Hisayoshi KUBOTA¹, Moe NIIJIMA¹, Hidetsugu FUJIGAKI², Yasuko YAMAMOTO², Toshitaka NABESHIMA³, Kuniaki SAITO² (1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Aichi, Japan, 2. Department of Disease Control and Prevention, Fujita Health University Graduate School of Health Science, Aichi, Japan, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan)